CCCC
C4 Therapeutics Inc.
$2.61
-$0.55(-17.41%)
54
Overall
--
Value
54
Tech
--
Quality
Market Cap
$224.90M
Volume
3.99M
52W Range
$1.09 - $7.14
Target Price
$13.25
EPS Estimates Overview
| Current Quarter | $-0.43 | Next Quarter | $-0.45 |
| Current Year | $-1.6 | Next Year | $-1.63 |
| QoQ Growth | -4.7% | YoY Growth | -1.9% |
| 3Y EPS CAGR | +5.8% | Target Price | $13.25 |
| Consensus | Buy | Upside | +407.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CCCC | $2.61 | -17.4% | 3.99M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |